Tech Company Financing Transactions
SGX Pharmaceuticals Funding Round
SGX Pharmaceuticals, operating out of Indianapolis, raised $7.5 million in investment from Apple Tree Partners, Atlas Venture and Index Ventures.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$7,499,900
Round
Undisclosed
Investors
Atlas Venture (Jean-François Formela)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Lilly Corporate Center
Indianapolis, IN 46285
USA
Indianapolis, IN 46285
USA
Phone
Website
Email Address
Not Recorded
Overview
SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Lechleiter
Browse more venture capital transactions:
Prev: 6/30/2005: Knovel venture capital transaction
Next: 6/30/2005: Amicus Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs